On the Record · Quest Diagnostics

Quest Diagnostics acquisitions, on the record

The businesses Quest Diagnostics bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
Haystack Oncology, Inc. Word for word“The acquisition was an all-cash transaction for $392 million, net of $1 million of cash acquired, which consisted of cash consideration of $304 million and contingent consideration initially estimated at $88 million.” 10-K for 2023	acquisition	—	$392 million, net of $1 million of cash acquired
select assets of the laboratory services business of New York-Presbyterian Word for word“On April 17, 2023, we completed the acquisition of select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the tri-state area and beyond, in an all cash transaction for $275 million.” 10-K for 2023	acquisition	On April 17, 2023	$275 million
select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health Word for word“We also completed our acquisition of select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health, a large integrated healthcare system in Maine.” 10-K for 2023	acquisition	—	—
Lenco Diagnostic Laboratories, Inc. Word for word“On February 12, 2024, we acquired select assets of Lenco, an independent clinical diagnostic laboratory provider serving physicians in New York, in an all-cash transaction for $111 million.” 10-K for 2024	acquisition	February 12, 2024	$111 million
PathAI Diagnostics Word for word“On June 10, 2024, we acquired select assets of PathAI Diagnostics, a business that provides anatomic and digital pathology laboratory services, in an all-cash transaction for $100 million.” 10-K for 2024	acquisition	June 10, 2024	$100 million
LifeLabs Inc. and BPC Lab Finance LP Word for word“On August 23, 2024, we acquired LifeLabs in an all-cash transaction for approximately CAN $1.35 billion (approximately USD $1 billion).” 10-K for 2024	acquisition	August 23, 2024	approximately CAN $1.35 billion (approximately USD $1 billion)
outreach laboratory services business of Allina Health Word for word“On September 16, 2024, we acquired select assets of the outreach laboratory services business of Allina, which serves providers and patients in Minnesota and Wisconsin, in an all-cash transaction for $230 million.” 10-K for 2024	acquisition	September 16, 2024	$230 million
laboratory business of three physician groups in New York Word for word“On September 30, 2024, we acquired the laboratory business of three physician groups in New York in an all-cash transaction for $300 million.” 10-K for 2024	acquisition	September 30, 2024	$300 million
outreach laboratory services business of OhioHealth Word for word“On October 13, 2024, we acquired select assets of the outreach laboratory services business of OhioHealth, which serves providers and patients in Ohio, in an all-cash transaction for $200 million.” 10-K for 2024	acquisition	October 13, 2024	$200 million
outreach laboratory services business of University Hospitals Word for word“On December 30, 2024, we acquired the outreach laboratory services business of University Hospitals, which serves providers and patients in Ohio, in an all-cash transaction for $183 million.” 10-K for 2024	acquisition	December 30, 2024	$183 million
select clinical testing and dialysis-related water testing assets of Fresenius Medical Care's wholly-owned Spectra Laboratories Word for word“In 2025, we acquired select clinical testing and dialysis-related water testing assets of Fresenius Medical Care's wholly-owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States.” 10-K for 2025	acquisition	In 2025	—
LifeLabs Word for word“In 2024, we acquired LifeLabs, a company that provides laboratory diagnostic information and digital health connectivity systems in Canada.” 10-K for 2025	acquisition	In 2024	—

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Cash paid for acquisitions (net of cash acquired)	Cash received from selling businesses	Goodwill from acquisitions
2016-12-31	$139 million	$295 million	$95 million
2017-12-31	$581 million	$1 million	$335 million
2018-12-31	$421 million	$2 million	$228 million
2019-12-31	$58 million	$0	$43 million
2020-12-31	$330 million	—	$247 million
2021-12-31	$331 million	—	$228 million
2022-12-31	$144 million	—	$121 million
2023-12-31	$611 million	—	$511 million
2024-12-31	$2.16 billion	—	$1.15 billion
2025-12-31	$101 million	—	$80 million

Deal filings since 2016

2026-05-08 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-08-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-07-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-11-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-05-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-12-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-03-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-05-26 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Quest Diagnostics’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.